🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To obtain short-term and long-term clinical safety information, in pediatri...
Status
Recruiting
Location
Children's National Hospital
Start Date
2022-06-30
Trial ID
NCT05040178
Treatments Being Tested
The purpose of this study is to conduct post-marketing surveillance of carg...
Status
Recruiting
Location
Children's National Medical Center
Start Date
2012-04
Trial ID
NCT03409003
A Phase IIIb (Three b), Randomized Multicentre Comparative Trial to Evaluat...
Status
Completed
Location
King Abdullah Specialist Children Hospital, King Abdulaziz Medical City
Start Date
2015-11
Trial ID
NCT02426775
Treatments Being Tested
The overall objective of this drug trial is to determine whether the treatm...
Status
Completed
Location
University of California Los Angeles
Start Date
2012-09-01
Trial ID
NCT01599286
Evaluate the Long Term Effectiveness \& Safety of the use of Carglumic Acid...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2019-11-28
Trial ID
NCT04284917
Treatments Being Tested
This study is based on the hypothesis that a new drug N-carbamylglutamate (...
Status
Unknown
Location
Childrens Research Institute
Start Date
2008-08
Trial ID
NCT00843921
Treatments Being Tested
Background: Very few drugs exist that treat hyperammonemia, specifically PA...
Status
Terminated
Location
University of California Los Angeles
Start Date
2012-09
Trial ID
NCT01597440
Treatments Being Tested
Hyperammonemia, which can cause brain damage, occurs in many different kind...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01341379
Treatments Being Tested
This is a prospective mixed-design study focused on the long-term managemen...
Status
Recruiting
Location
Hopital Des Enfants, CHU de Bordeaux-GH Pellegrin
Start Date
2019-01-15
Trial ID
NCT04176523
Treatments Being Tested